Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2024-08-15 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
北京诺禾致源科技股份有限公司关于持股5%以上股东权益变动比例达到1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement regarding changes in shareholding percentages by shareholders holding more than 5% of the company's shares. It details the reduction in shares held by specific shareholders, the dates and methods of share reduction, and confirms that the controlling shareholder did not participate in the reduction. The document references compliance with securities laws and disclosure obligations. There is no financial statement, audit information, or management discussion of financial results. The content fits the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds.
2024-08-15 Chinese
北京诺禾致源科技股份有限公司2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2024 半年度报告摘要' which translates to '2024 Half-Year Report Summary'. It contains detailed financial data such as total assets, net profit, revenue, earnings per share, and shareholder information for the half-year period. The document explicitly states it is a summary of the half-year report and references the full half-year report for more details. The presence of comprehensive financial data and management discussion indicates this is a financial report for a period shorter than a full fiscal year. The document length is 3090 characters, which is relatively short but contains substantive financial data, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2024-08-14 Chinese
北京诺禾致源科技股份有限公司关于“提质增效重回报”2024年度行动方案半年度评估报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2024年度行动方案半年度评估报告" which translates to a "2024 Annual Action Plan Mid-Year Evaluation Report." It contains detailed operational and financial performance data for the first half of 2024, including revenue, net profit, R&D investment, dividend payments, share repurchases, governance activities, and strategic initiatives. The document is comprehensive and includes substantive financial data and management discussion of business trends and outlook. It is not merely an announcement or a brief summary but a detailed mid-year report on company performance and strategy execution. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is 3057 characters, which is relatively short but contains detailed financial and operational data, supporting classification as an IR rather than a brief announcement or regulatory filing.
2024-08-14 Chinese
北京诺禾致源科技股份有限公司2024年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2024 Half-Year Special Report on the Deposit and Actual Use of Raised Funds" by Beijing Novogene Technology Co., Ltd. It details the amounts raised through stock issuance in 2021 and 2022, the use and management of these funds up to June 30, 2024, including changes in investment projects, cash management of idle funds, and compliance with regulatory requirements. The document includes detailed tables showing the use of raised funds, changes in projects, and related approvals by the board and shareholders. It is a comprehensive report focused on the management and use of capital raised by the company, specifically addressing fundraising and capital usage. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document is not an announcement of a report but a substantive report itself, with over 12,000 characters and detailed financial and operational data related to fundraising and capital use. Therefore, the correct classification is CAP with high confidence.
2024-08-14 Chinese
北京诺禾致源科技股份有限公司第三届监事会第十五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Beijing Novogene Technology Co., Ltd. regarding the review and approval of the company's 2024 semi-annual report and a special report on the use of raised funds. It includes statements about the legality, accuracy, and completeness of the semi-annual report and the compliance of the fundraising usage with regulations. The document references the full 2024 semi-annual report and the special fundraising report being published on the Shanghai Stock Exchange website, indicating this document itself is an announcement of the Supervisory Board's meeting resolutions rather than the full semi-annual report or the fundraising report. The document length is short (1367 characters), and it primarily serves as a formal announcement of meeting decisions and approvals. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance confirmation rather than the actual Interim/Quarterly Report (IR) or a Report Publication Announcement (RPA) because it contains substantive supervisory board resolutions and opinions rather than just a notice of publication.
2024-08-14 Chinese
北京诺禾致源科技股份有限公司关于召开2024年半年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of a 2024 half-year performance explanation meeting (业绩说明会) for investors. It references the company's 2024 half-year report already published on August 15, 2024, and invites investors to participate in an interactive session to discuss the half-year financial results. The document does not contain the actual financial data or detailed report itself but serves as a notice for the upcoming investor presentation event. Given the content and length (1456 characters), it fits the category of an Investor Presentation announcement rather than the report itself or a regulatory filing. Therefore, the appropriate classification is Investor Presentation (IP).
2024-08-14 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.